Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 840

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 7
Chunk 840
---
 Foreign exchange expense 
     (289) 
     (28)
  
    Interest expense 
     (303) 
     - 
  
    Interest income 
     62  
     206 
  
    Change in fair value of convertible rights 
     299  
     - 
  
    Change in fair value of warrant liabilities 
     (21,925) 
     - 
  
    Warrant issuance costs 
     (129) 
     - 
  
    Loss on extinguishment 
     (1,472) 
     - 
  
    ELOC commitment fee 
     (1,095) 
     - 
  
    Total other income, net 
     (23,096) 
     11,612 
  
    Loss before income tax expense 
     (46,885) 
     (18,429)
  
    Income tax expense 
     -  
     (30)
  
    Net loss 
    $(46,885) 
    $(18,459)
  
    Other comprehensive income/ (loss): 

    Currency translation adjustment, net of tax 
     208  
     (77)
  
    Total comprehensive loss 
    $(46,677) 
    $(18,536)
  
    Net loss per share: Basic and diluted 
    $(1.35) 
     (1.15)
  
    Weighted average number of shares outstanding, basic and diluted 
     34,454,269  
     16,164,338 

The accompanying notes are an integral part of
these consolidated financial statements.

F-4

INCANNEX HEALTHCARE INC.

Consolidated Statements of Stockholders’
Equity (Deficit)

(in thousands, except share amounts)

(expressed
in U.S. Dollars, unless otherwise stated)

    Common Stock  
    Additional Paid-in capital  
    Accumulated deficit  
    Foreign currency translation reserve  
    Total stockholders’ equity (deficit) 

    Share  
    Amount  
    Amount  
    Amount  
    Amount  
    Amount 

    #  
    $  
    $  
    $  
    $  
    $ 
  
    Balance at June 30, 2023 
     15,873,113  
     2  
     116,290  
     (92,212)